HER-2 status of the primary breast cancer in patients with late disease relapse

被引：0
|
作者：
Tomasevic, Zorica [1 ]
Jovanovic, Danica [1 ]
Radosevic-Jelic, Ljiljana [1 ]
Tomasevic, Zoran [1 ]
Vasovic, Suzana [1 ]
Stamatovic, Ljiljana [1 ]
Jelic, Svetislav [1 ]
Spasic, Jelena [1 ]
机构：
[1] Inst Oncol & Radiol Serbia, Belgrade, Serbia
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [1] Serum HER-2 as an Early Predictor of Disease Relapse in Breast Cancer
    Soerensen, D. P.
    Madsen, J. S.
    Langkjer, S. T.
    Jakobsen, S. H.
    Oestergaard, B.
    Brandslund, I
    TUMOR BIOLOGY, 2008, 29 : 80 - 80
  • [2] HER 2 Positive Breast Cancer: Late Relapse or New Primary?
    Synnott, P.
    Keane, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : 286 - 286
  • [3] Her-2 status in breast cancer patients with orbital metastases
    Albrecht, S.
    Zilli, T.
    Popowski, Y.
    Balmer, Majno S.
    Weber, D. C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 172 - 172
  • [4] Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
    Mokhtari, Maral
    Khosravi, Mohammad Hadi
    MIDDLE EAST JOURNAL OF CANCER, 2021, 12 (04) : 483 - 490
  • [5] Serum HER-2 concentration in patients with primary breast cancer
    Kong, SY
    Kang, JH
    Kwon, Y
    Kang, HS
    Chung, KW
    Kang, SH
    Lee, DH
    Ro, J
    Lee, ES
    JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (04) : 373 - 376
  • [6] Her-2 Status on Primary Breast Cancer and Concurrent Lymph Node Metastasis
    Loona, A.
    Dosanj, P.
    Deb, R.
    JOURNAL OF PATHOLOGY, 2015, 237 : S30 - S30
  • [7] Estrogen, Progesterone, and Her-2/neu Receptor Expression Discrepancy in Primary Tumors and In-Breast Relapse in Patients with Breast Cancer
    Mavrova, Russalina
    Radosa, Julia
    Schmitt, Kai
    Bohle, Rainer M.
    Rody, Achim
    Solomayer, Erich-Franz
    Juhasz-Boeess, Ingolf
    BREAST JOURNAL, 2014, 20 (03): : 322 - 324
  • [8] Correlation between Her-2 status in primary tumour and response to anastrozole in patients with metastatic breast cancer
    Drev, P.
    Golouh, R.
    Snoj, N.
    Cufer, T.
    EJC SUPPLEMENTS, 2004, 2 (03): : 178 - 178
  • [9] DOES HER2 STATUS OF THE PRIMARY BREAST CANCERS INFLUENCE TIME TO LATE RELAPSE?
    Tomasevic, Z.
    Radosevic-Jelic, L.
    Tomasevic, Z.
    Milovanovic, Z.
    Jelic, S.
    ANNALS OF ONCOLOGY, 2009, 20 : 50 - 51
  • [10] Pattern of brain metastatic disease according to HER-2 and ER receptor status in breast cancer patients
    Lekanidi, K.
    Evans, A. L.
    Shah, J.
    Jaspan, T.
    Baker, L.
    Evans, A. J.
    CLINICAL RADIOLOGY, 2013, 68 (10) : 1070 - 1073
12345